Foot News and Research

RSS

UCLA receives funds for oral cancer research training

The UCLA School of Dentistry consistently ranks among the country's top dental schools in National Institutes of Health funding. During the past three fiscal years, the school has secured nearly $30 million in grants for oral cancer research and research training. Now, the dental school has received a major infusion of construction funding for the creation of the UCLA Yip Center for Oral/Head & Neck Oncology Research.

15 Sep 2009

FDA clearance for PRO-STIM bone graft substitute

Wright Medical Group, Inc., a global orthopaedic medical device company, today announced the 510K clearance of PRO-STIM™ Injectable Osteoinductive Bone Graft Substitute. PRO-STIM™ graft is a composite grafting material that is injected through a small needle, hardens, and is replaced by the patient’s new bone over time.

14 Sep 2009

Concept of wellness can yield greater savings

According to a new survey released today, 90 percent of plan sponsors believe that minimal attention to personal health and increased incidence of chronic illness such as diabetes and heart disease are at the root of rising health care costs.

14 Sep 2009

Data from Phase III clinical trial of TYSABRI presented at ECTRIMS

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced data presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) showing the potential of TYSABRI® (natalizumab) to redefine successful multiple sclerosis (MS) therapy.

14 Sep 2009

New outpatient center opened in Westchase, Florida by The Graham Group

The Graham Group, Inc. announced in August the opening of the BayCare Outpatient Center in Westchase, Florida. The BayCare Outpatient Center is a four-story, 55,000 square-foot medical office building located north of Tampa in Hillsborough County.

11 Sep 2009

Acorda Therapeutics announces Phase 3 Fampridine-SR trial findings

Data from a long-term open-label extension study from the first Phase 3 Fampridine-SR trial, known as MS-F203, showed that 24.9% of extension study participants with multiple sclerosis (MS) met the criteria as Extension Timed Walk Responders (ETWRs) after one year of treatment and demonstrated improved walking speed over a two year period.

10 Sep 2009

North Carolina Biotechnology Center establishes Research Triangle Park headquarters

To continue the state life science industry’s record-setting growth rate, the North Carolina Biotechnology Center, with the help of statewide partners, is building an addition to its Research Triangle Park headquarters.

10 Sep 2009

Wright Medical Group launches ORTHOLOC Polyaxial Locked Plating System

Wright Medical Group, Inc., a global orthopaedic medical device company, today announced the launch of the ORTHOLOC Polyaxial Locked Plating System for surgical treatment of foot and ankle fractures.

10 Sep 2009

Dana-Farber Cancer Institute reaches milestone: $1 billion raised in campaign

Dana-Farber Cancer Institute today announced it has reached its $1 billion Mission Possible: The Dana-Farber Campaign to Conquer Cancer fundraising goal one year early. The first hospital in New England to set and reach a $1 billion campaign goal, Dana-Farber will continue to raise funds for campaign priorities until Sept. 30, 2010, when the campaign was scheduled to end.

9 Sep 2009

BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announces its schedule for filing with the U.S. government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy and RecoveryRx™ products. In these applications BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy product for indications for the treatment of heel and foot pain, and for pain relief relative to general musculoskeletal complaints.

9 Sep 2009

Delcath Systems begins operations facility in Queensbury, New York

Delcath Systems, Inc. (Nasdaq: DCTH), a Manhattan headquartered medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that it has signed a three-year lease with the option to buy on a 10,000 square foot facility in Queensbury, New York in which it plans to locate manufacturing of its Percutaneous Hepatic Perfusion (PHP(TM)) System.

3 Sep 2009

NIH grants $8 million to Fox Chase Cancer Center for cancer research

The Fox Chase Cancer Center has received an $8 million grant from the National Center for Research Resources of the National Institutes of Health (NCRR/NIH) to expand their laboratory animal research facility. The new facility will support advanced research into the fundamental biological processes underlying cancer, opening the way for the development of new treatments. The funds for the grant were made available through the American Recovery and Reinvestment Act.

3 Sep 2009

XerGame products to be showcased at the US Open Tennis Championships

XerTech Inc., a leading manufacturer, seller, and distributer of cutting-edge, interactive fitness systems, today announced that it will showcase its XerGame products at the US Open Tennis Championships, starting today, August 31, and running through the end of the event on September 13, 2009.

31 Aug 2009

Caltech neuroscientists emphasize on the neural mechanisms involved in social behaviour

In a finding that sheds new light on the neural mechanisms involved in social behavior, neuroscientists at the California Institute of Technology (Caltech) have pinpointed the brain structure responsible for our sense of personal space.

30 Aug 2009

American Podiatric Medical Association refutes Arizona Congressman's statement

In an interview this week with FOX News' Neil Cavuto, Congressman John Shadegg (R-AZ) said podiatry was an "esoteric demand that most people don't have or don't need," during a discussion on health care reform.

29 Aug 2009

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Cardium Therapeutics today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds.

28 Aug 2009

Distribution agreement signed between Cardiovascular Systems and Asahi Intecc

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed an exclusive distribution agreement with Asahi Intecc Co., Ltd., based in Japan, to market its peripheral guide wire line in the United States.

28 Aug 2009

$3 million grant to help Parkinson's Institute and Clinical Center to continue cutting-edge research

The Parkinson's Institute and Clinical Center (PI) is very excited to announce the receipt of a $3 million challenge grant from the Brin Foundation as the lead gift in the PI's $15 million Capital Campaign - "A Campaign to Conquer Parkinson's Disease." The "Challenge" feature of the grant invites individuals, foundations and corporations to partner with the Brin Foundation in support of Parkinson's research.

28 Aug 2009

Adventist Medical Center receives the Community Value Index Five-Star hospital award

Adventist Medical Center (AMC) has received the Community Value Index (CVI) Five-Star hospital award for the third consecutive year. Developed by Cleverley and Associates, the national recognition signifies AMC’s dedication to meeting the healthcare needs of the community in a financially responsible, efficient and effective manner.

27 Aug 2009

Inventor of the SPIDER Limb Positioner wins a $10,000 Manning Innovation Award

Calgary biomed engineer Brent King is to win a $10,000 Manning Innovation Award for inventing a unique device to accurately and securely position a surgical patient's limb.

27 Aug 2009